We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BITGF market cap is 1.19B. The company's latest EPS is SEK 3.0747 and P/E is 4.82.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 1.1B | 1.09B | 1.23B | 1.57B | 1.86B |
| Operating Income | 205.71M | 186M | 255M | 292M | 299M |
| Net Income | 186.82M | 175.33M | 205M | 268M | 246M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 1.34B | 1.43B | 1.99B | 2.34B | 4.93B |
| Total Liabilities | 460.18M | 444.4M | 621M | 702M | 1.27B |
| Total Equity | 875.5M | 990.04M | 1.37B | 1.64B | 3.66B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | 211.81M | 279.05M | 353M | 340M | 284M |
| Investing | -85.68M | -61.32M | -341M | -84M | 35M |
| Financing | -119.21M | -22.72M | -82M | -133M | -142M |
| Market Cap | 1.19B |
| Price to Earnings Ratio | 4.82 |
| Price to Sales Ratio | 0.64 |
| Price to Cash Ratio | 2 |
| Price to Book Ratio | 0.32 |
| Dividend Yield | - |
| Shares Outstanding | 80.01M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -10.12% |
| 52 Week High | 18.52 |
| 52 Week Low | 14.63 |
| Spread (Intraday) | 1.11 (7.23%) |
| Company Name | Biotage AB (PK) |
| Address |
vimpelgatan 5 uppsala SE-751 03 |
| Website | https://www.biotage.com |
| Industry | biogenetic (human) (H4) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
